Old drug new use--amoxapine and its metabolites as potent bacterial β-glucuronidase inhibitors for alleviating cancer drug toxicity.
about
Real-time imaging of intestinal bacterial β-glucuronidase activity by hydrolysis of a fluorescent probeStructure and Inhibition of Microbiome β-Glucuronidases Essential to the Alleviation of Cancer Drug ToxicityNew Role for FDA-Approved Drugs in Combating Antibiotic-Resistant BacteriaGut microbiota modulation of chemotherapy efficacy and toxicity.Preventive Effects of a Chinese Herbal Formula, Shengjiang Xiexin Decoction, on Irinotecan-Induced Delayed-Onset Diarrhea in Rats.Microbiota as a mediator of cancer progression and therapy.Gut microbiome interactions with drug metabolism, efficacy, and toxicity.The Inhibitory Effect of Ciprofloxacin on the β-Glucuronidase-mediated Deconjugation of the Irinotecan Metabolite SN-38-G.Combating Multidrug-Resistant Pathogens with Host-Directed Nonantibiotic Therapeutics.The role of gut microbiota in the modulation of drug action: a focus on some clinically significant issues.Individualization of Irinotecan Treatment: A Review of Pharmacokinetics, Pharmacodynamics, and Pharmacogenetics.Discovery of specific inhibitors for intestinal E. coli β-glucuronidase through in silico virtual screening.Two birds, one stone: hesperetin alleviates chemotherapy-induced diarrhea and potentiates tumor inhibition.Gut microbiota, chemotherapy and the host: the influence of the gut microbiota on cancer treatment
P2860
Q33784710-49447079-2CAB-4501-BD34-EC1E46D806F4Q34493889-0F02FBF5-8D09-4784-B1F3-661E177EFC1BQ35986316-6246B51B-3CB0-4141-971E-0D5AF27A633FQ36300217-554186BB-9DC4-411F-8A4B-0CFAF265C939Q37607371-1E18FB0B-2054-4541-8FFC-4A43F47165A2Q38935534-E0B99B76-13F1-4FC1-8479-FCB140C2360DQ38945423-D97E98E1-1C83-4A4F-989A-350526CD359AQ40929836-B3D4A389-62C2-427A-A776-6F7065454345Q47721065-12E65A2E-EE9D-42A9-A7C5-5B2D48525441Q50054146-96836414-97A8-46D1-A220-40B12CE4D477Q52362144-8E1EEF1A-48C4-40ED-AEE1-49F7EC52271BQ54271048-6418C5E4-6290-48AA-85AA-73A4E007B0A8Q55408407-4F2EA499-D764-47DF-A849-F17F81140F5CQ58762645-459283C4-B652-4081-8C0D-2D3D3AB09103
P2860
Old drug new use--amoxapine and its metabolites as potent bacterial β-glucuronidase inhibitors for alleviating cancer drug toxicity.
description
2014 nî lūn-bûn
@nan
2014 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Old drug new use--amoxapine an ...... eviating cancer drug toxicity.
@ast
Old drug new use--amoxapine an ...... eviating cancer drug toxicity.
@en
type
label
Old drug new use--amoxapine an ...... eviating cancer drug toxicity.
@ast
Old drug new use--amoxapine an ...... eviating cancer drug toxicity.
@en
prefLabel
Old drug new use--amoxapine an ...... eviating cancer drug toxicity.
@ast
Old drug new use--amoxapine an ...... eviating cancer drug toxicity.
@en
P2093
P2860
P1476
Old drug new use--amoxapine an ...... eviating cancer drug toxicity.
@en
P2093
Alexandria T Phan
Alfred L Williams
John E Scott
Stephen T C Wong
Syed Ahmad
Timothy Liu
Xiaoping Zhu
P2860
P304
P356
10.1158/1078-0432.CCR-14-0395
P407
P50
P577
2014-04-29T00:00:00Z